Previously we have discussed neuropathy in the context of diabetic neuropathy, back-related neuropathies and the like. However, this week we are going to discuss an autoimmune neuropathy called ...
Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting about 1 in 100,000 people, according to the U.S. Centers for Disease Control and Prevention. While GBS is more common in men and ...
A new Guillain-Barré syndrome mimic that appeared to be triggered by mild infection emerged in children with biallelic RCC1 variants, a case series showed. One of the first cases was seen in a ...
A 56-year-old woman presents to the hospital complaining of generalized weakness that has been progressing for the past month. Her initial symptoms involved numbness and weakness in her legs and lower ...
The Johnson & Johnson COVID-19 vaccine will now include a U.S. Food and Drug Administration warning because of the chance of an increase in the risk for a rare neurological disorder. The disorder, ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Five more cases of Guillain–Barré syndrome (GBS) in association with COVID-19 have been identified, ...
LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, ...
The Johnson & Johnson COVID-19 vaccine will now include a U.S. Food and Drug Administration warning because of the chance of an increase in the risk for a rare neurological disorder. The disorder, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback